Cargando…
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
The aim of the present study was to verify whether the baseline circulating tumor cell (CTC) count might serve as a predictor of overall survival (OS) and metastasis-free survival (MFS) in patients with high-risk prostate cancer (PCa) during a follow-up period of at least 5 years. CTCs were enumerat...
Autores principales: | Cieślikowski, Wojciech A., Milecki, Piotr, Świerczewska, Monika, Ida, Agnieszka, Kasperczak, Michał, Jankowiak, Agnieszka, Nowicki, Michał, Pantel, Klaus, Alix-Panabières, Catherine, Zabel, Maciej, Antczak, Andrzej, Budna-Tukan, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144132/ https://www.ncbi.nlm.nih.gov/pubmed/37108995 http://dx.doi.org/10.3390/jpm13040608 |
Ejemplares similares
-
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2020) -
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
por: Budna-Tukan, Joanna, et al.
Publicado: (2019) -
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
por: Cieślikowski, Wojciech A., et al.
Publicado: (2021) -
Reasons behind the Delayed Diagnosis of Testicular Cancer: A Retrospective Analysis
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023) -
Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
por: Kamińska, Paula, et al.
Publicado: (2021)